Send the following on WhatsApp
Continue to ChatTelaprevir with Adjusted dose of Ribavirin in naive CHC-G1: Efficacy And Treatment in CHC in Hemodialysis population. TARGET C Trial- A Placebo Randomized Control Clinical Trial https://www.sages.org/meetings/annual-meeting/abstracts-archive/telaprevir-with-adjusted-dose-of-ribavirin-in-naive-chc-g1-efficacy-and-treatment-in-chc-in-hemodialysis-population-target-c-trial-a-placebo-randomized-control-clinical-trial/